NASDAQ · NXPL
Technology · Software - Application
$8.91
Down-$0.47 (-4.96%)
Updated Sep 7, 2026, 1:10 PM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
NXPL closed at $8.91 after 20 trading sessions, up 40.09% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $9.28 | $9.49 | $8.91 | $8.91 | 13.9K |
| Sep 3, 2026 | $9.31 | $9.705 | $8.70 | $9.375 | 84.94K |
| Sep 2, 2026 | $9.68 | $9.944 | $9.22 | $9.26 | 47.57K |
| Sep 1, 2026 | $9.56 | $9.826 | $9.56 | $9.64 | 5.41K |
| Aug 31, 2026 | $9.17 | $9.87 | $9.17 | $9.68 | 16.72K |
| Aug 28, 2026 | $9.40 | $9.85 | $9.10 | $9.26 | 117.07K |
| Aug 27, 2026 | $9.645 | $9.85 | $9.32 | $9.32 | 21.07K |
| Aug 26, 2026 | $9.16 | $9.66 | $9.01 | $9.31 | 63.41K |
| Aug 25, 2026 | $8.9855 | $9.38 | $8.66 | $9.09 | 284.68K |
| Aug 24, 2026 | $8.97 | $9.49 | $8.85 | $9.125 | 21.73K |
| Aug 21, 2026 | $8.94 | $9.17 | $8.74 | $9.15 | 24.57K |
| Aug 20, 2026 | $8.50 | $8.80 | $8.355 | $8.57 | 15.17K |
| Aug 19, 2026 | $8.30 | $8.80 | $7.9917 | $8.53 | 28.29K |
| Aug 18, 2026 | $8.37 | $8.7421 | $8.055 | $8.07 | 10.74K |
| Aug 17, 2026 | $8.405 | $9.04 | $8.35 | $8.46 | 36.11K |
| Aug 14, 2026 | $8.14 | $9.1699 | $8.06 | $8.24 | 69.55K |
| Aug 13, 2026 | $6.75 | $8.30 | $6.64 | $8.11 | 164.55K |
| Aug 12, 2026 | $6.49 | $7.0305 | $6.49 | $6.71 | 48.01K |
| Aug 11, 2026 | $6.83 | $6.83 | $6.40 | $6.47 | 80.06K |
| Aug 10, 2026 | $6.4588 | $6.785 | $6.32 | $6.36 | 28.13K |
The latest Smart Investors Daily articles mentioning NXPL.
NXPL research
Company profile and research snapshot.
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 24, 2026 | Litchfield Hills | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 13, 2026
NextPlat (NASDAQ:NXPL) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to
Benzinga · Aug 13, 2026
NextPlat (NASDAQ:NXPL) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.21) by 76.19 percent. This is a 92.86 percent increase over losses of $(0.70) per share from the
Benzinga · Jul 15, 2026
NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels
Benzinga · Jun 24, 2026
Litchfield Hills analyst Theodore O'Neill initiates coverage on NextPlat (NASDAQ:NXPL) with a Buy rating and announces Price Target of $11.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NXPL.
